AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha ...
Plus: iRobot unveils its new robo vacs, JBL pimps its most beloved speakers, a bright future for TCL TVs, and more.